Insider Monitor Realtime Top 10
  1. Company List - K
  2. KERX

Insider Trading activities at Keryx Biopharmaceuticals Inc (KERX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Keryx Biopharmaceuticals Inc (KERX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Keryx Biopharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1114220.

Total stock buying since 2014: $351,218.
Total stock sales since 2014: $13,656,435.
Total stock option exercises since 2014: $395,777.


10 insiders reported insider trading activities at Keryx Biopharmaceuticals Inc (KERX):
▪ Insider trading activities of Bentsur Ron
▪ Insider trading activities of Madison Greg
▪ Insider trading activities of Cameron Kevin J
▪ Insider trading activities of Holmes Scott A
▪ Insider trading activities of Gilman Steven C
▪ Insider trading activities of Tarnok Michael P.
▪ Insider trading activities of Adams Brian
▪ Insider trading activities of Neylan John F.
▪ Insider trading activities of Oliviero James F Iii
▪ Insider trading activities of Carberry Christine A.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Keryx Biopharmaceuticals Inc (KERX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2018 0 $0 90,902 $403,816 10,000 $4,800
2017 0 $0 84,937 $469,978 0 $0
2016 0 $0 38,562 $202,038 0 $0
2015 46,364 $351,218 35,846 $396,231 41,611 $110,477
2014 0 $0 835,588 $12,184,372 25,000 $280,500

Table 2. Monthly summary of insider trading at Keryx Biopharmaceuticals Inc (KERX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 0 $0 10,469 $33,710 0 $0
2018-11 0 $0 2,311 $6,401 0 $0
2018-10 0 $0 4,547 $14,406 0 $0
2018-08 0 $0 2,371 $7,207 0 $0
2018-07 0 $0 5,657 $23,108 0 $0
2018-06 0 $0 3,001 $15,131 10,000 $4,800
2018-05 0 $0 5,316 $28,837 0 $0
2018-04 0 $0 6,855 $32,246 0 $0
2018-02 0 $0 32,273 $155,232 0 $0
2018-01 0 $0 18,102 $87,538 0 $0
2017-10 0 $0 12,151 $75,626 0 $0
2017-07 0 $0 12,467 $89,768 0 $0
2017-05 0 $0 8,445 $50,414 0 $0
2017-04 0 $0 5,071 $29,379 0 $0
2017-02 0 $0 1,611 $8,812 0 $0
2017-01 0 $0 45,192 $215,979 0 $0
2016-11 0 $0 1,559 $7,779 0 $0
2016-10 0 $0 5,118 $24,995 0 $0
2016-08 0 $0 4,866 $20,532 0 $0
2016-07 0 $0 8,831 $63,582 0 $0
2016-04 0 $0 7,663 $38,449 0 $0
2016-02 0 $0 1,938 $6,259 0 $0
2016-01 0 $0 8,587 $40,442 0 $0
2015-11 5,000 $26,628 1,638 $8,484 0 $0

Table 3. Detailed insider trading at Keryx Biopharmaceuticals Inc (KERX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-11 Carberry Christine A. (Chief Operating Officer) Sale 10,469 3.22 33,710
2018-11-15 Neylan John F. (Chief Medical Officer) Sale 1,156 2.77 3,202
2018-11-15 Holmes Scott A (Chief Financial Officer) Sale 1,155 2.77 3,199
2018-10-29 Neylan John F. (Chief Medical Officer) Sale 1,253 3.07 3,846
2018-10-29 Holmes Scott A (Chief Financial Officer) Sale 1,254 3.07 3,849
2018-10-18 Carberry Christine A. (Chief Operating Officer) Sale 2,040 3.29 6,711
2018-08-15 Neylan John F. (Chief Medical Officer) Sale 1,186 3.04 3,605
2018-08-15 Holmes Scott A (Chief Financial Officer) Sale 1,185 3.04 3,602
2018-07-30 Neylan John F. (Chief Medical Officer) Sale 1,282 3.86 4,948
2018-07-30 Holmes Scott A (Chief Financial Officer) Sale 2,354 3.86 9,086
2018-07-18 Carberry Christine A. (Chief Operating Officer) Sale 2,021 4.49 9,074
2018-06-18 Cameron Kevin J Sale 1,667 4.98 8,301
2018-06-15 Cameron Kevin J Option Ex 10,000 .48 4,800
2018-06-11 Gilman Steven C Sale 1,334 5.12 6,830
2018-05-29 Cameron Kevin J Sale 1,667 5.22 8,701
2018-05-29 Gilman Steven C Sale 1,333 5.22 6,958
2018-05-15 Neylan John F. (Chief Medical Officer) Sale 1,158 5.69 6,589
2018-05-15 Holmes Scott A (Chief Financial Officer) Sale 1,158 5.69 6,589
2018-04-30 Neylan John F. (Chief Medical Officer) Sale 1,311 4.67 6,122
2018-04-30 Holmes Scott A (Chief Financial Officer) Sale 2,407 4.67 11,240
2018-04-23 Neylan John F. (Chief Medical Officer) Sale 1,111 4.59 5,099
2018-04-18 Carberry Christine A. (Chief Operating Officer) Sale 2,026 4.83 9,785
2018-02-15 Neylan John F. (Chief Medical Officer) Sale 5,652 4.81 27,186
2018-02-15 Adams Brian (General Counsel and Secretary) Sale 5,652 4.81 27,186
2018-02-15 Madison Greg (President and CEO) Sale 15,318 4.81 73,679
2018-02-15 Holmes Scott A (Chief Financial Officer) Sale 5,651 4.81 27,181
2018-01-29 Neylan John F. (Chief Medical Officer) Sale 1,541 4.81 7,412
2018-01-29 Adams Brian (General Counsel and Secretary) Sale 1,541 4.81 7,412
2018-01-29 Holmes Scott A (Chief Financial Officer) Sale 2,830 4.81 13,612
2018-01-23 Neylan John F. (Chief Medical Officer) Sale 1,322 4.92 6,504
2018-01-18 Carberry Christine A. (Chief Operating Officer) Sale 9,048 4.87 44,063
2018-01-05 Adams Brian (General Counsel and Secretary) Sale 753 4.69 3,531
2018-01-05 Madison Greg (President and CEO) Sale 1,067 4.69 5,004
2017-10-30 Neylan John F. (Chief Medical Officer) Sale 1,405 6.03 8,472
2017-10-30 Adams Brian (General Counsel and Secretary) Sale 1,405 6.03 8,472
2017-10-30 Madison Greg (President and CEO) Sale 4,055 6.03 24,451
2017-10-30 Holmes Scott A (Chief Financial Officer) Sale 2,582 6.03 15,569
2017-10-23 Neylan John F. (Chief Medical Officer) Sale 1,179 6.53 7,698
2017-10-05 Adams Brian (General Counsel and Secretary) Sale 630 7.19 4,529
2017-10-05 Madison Greg (President and CEO) Sale 895 7.19 6,435
2017-07-31 Neylan John F. (Chief Medical Officer) Sale 1,445 7.14 10,317
2017-07-31 Adams Brian (General Counsel and Secretary) Sale 1,445 7.14 10,317
2017-07-31 Madison Greg (President and CEO) Sale 4,131 7.14 29,495
2017-07-31 Holmes Scott A (Chief Financial Officer) Sale 1,445 7.14 10,317
2017-07-28 Holmes Scott A (Chief Financial Officer) Sale 1,236 6.96 8,602
2017-07-24 Neylan John F. (Chief Medical Officer) Sale 1,214 7.27 8,825
2017-07-05 Adams Brian (General Counsel and Secretary) Sale 641 7.67 4,916
2017-07-05 Madison Greg (President and CEO) Sale 910 7.67 6,979
2017-05-01 Neylan John F. (Chief Medical Officer) Sale 1,441 5.97 8,602
2017-05-01 Adams Brian (General Counsel and Secretary) Sale 1,441 5.97 8,602
2017-05-01 Madison Greg (President and CEO) Sale 4,122 5.97 24,608
2017-05-01 Holmes Scott A (Chief Financial Officer) Sale 1,441 5.97 8,602
2017-04-28 Holmes Scott A (Chief Financial Officer) Sale 1,219 5.89 7,179
2017-04-24 Neylan John F. (Chief Medical Officer) Sale 1,209 5.73 6,927
2017-04-17 Adams Brian (General Counsel and Secretary) Sale 1,090 5.75 6,267
2017-04-05 Adams Brian (General Counsel and Secretary) Sale 642 5.80 3,723
2017-04-05 Madison Greg (President and CEO) Sale 911 5.80 5,283
2017-02-09 Madison Greg (President and CEO) Sale 1,611 5.47 8,812
2017-01-30 Neylan John F. (Chief Medical Officer) Sale 6,984 4.65 32,475
2017-01-30 Adams Brian (General Counsel and Secretary) Sale 6,984 4.65 32,475
2017-01-30 Madison Greg (President and CEO) Sale 18,248 4.65 84,853
2017-01-30 Holmes Scott A (Chief Financial Officer) Sale 8,447 4.65 39,278
2017-01-23 Neylan John F. (Chief Medical Officer) Sale 1,428 5.39 7,696
2017-01-17 Adams Brian (VP and General Counsel) Sale 1,265 6.24 7,893
2017-01-05 Adams Brian (VP and General Counsel) Sale 759 6.16 4,675
2017-01-05 Madison Greg (President and CEO) Sale 1,077 6.16 6,634
2016-11-09 Madison Greg (President and CEO) Sale 1,559 4.99 7,779
2016-10-28 Holmes Scott A (Chief Financial Officer) Sale 1,237 4.44 5,492
2016-10-24 Neylan John F. (Chief Medical Officer) Sale 1,211 4.72 5,715
2016-10-17 Adams Brian (VP and General Counsel) Sale 1,106 4.86 5,375
2016-10-05 Adams Brian (VP and General Counsel) Sale 647 5.38 3,480
2016-10-05 Madison Greg (President and CEO) Sale 917 5.38 4,933
2016-08-09 Madison Greg (President and CEO) Sale 3,244 4.22 13,688
2016-07-29 Holmes Scott A (Chief Financial Officer) Sale 4,935 7.36 36,321
2016-07-25 Neylan John F. (Chief Medical Officer) Sale 1,217 7.43 9,042
2016-07-15 Adams Brian (VP and General Counsel) Sale 1,083 7.01 7,591
2016-07-05 Adams Brian (VP and General Counsel) Sale 660 6.66 4,395
2016-07-05 Madison Greg (President and CEO) Sale 936 6.66 6,233
2016-04-25 Neylan John F. (Chief Medical Officer) Sale 4,766 5.21 24,830
2016-04-15 Adams Brian (VP and General Counsel) Sale 1,060 5.05 5,353
2016-04-05 Adams Brian (VP and General Counsel) Sale 759 4.50 3,415
2016-04-05 Madison Greg (President and CEO) Sale 1,078 4.50 4,851
2016-02-09 Madison Greg (President and CEO) Sale 1,938 3.23 6,259
2016-01-15 Adams Brian (VP and General Counsel) Sale 1,322 3.30 4,362
2016-01-06 Adams Brian (VP and General Counsel) Sale 3,004 5.16 15,500
2016-01-06 Madison Greg (President and CEO) Sale 4,261 4.83 20,580
2015-11-09 Madison Greg (President and CEO) Sale 1,638 5.18 8,484
2015-11-04 Holmes Scott A (Chief Financial Officer) Buy 1,328 5.40 7,171
2015-11-03 Holmes Scott A (Chief Financial Officer) Buy 3,672 5.30 19,457
2015-10-15 Adams Brian (VP and General Counsel) Sale 1,011 4.01 4,054
2015-08-21 Holmes Scott A (Chief Financial Officer) Buy 5,000 5.72 28,590
2015-08-20 Madison Greg (President and CEO) Buy 9,984 5.68 56,759
2015-08-12 Neylan John F. (Chief Medical Officer) Buy 10,000 6.20 62,000
2015-08-10 Madison Greg (President and CEO) Sale 1,683 6.07 10,215
2015-07-31 Holmes Scott A (Chief Financial Officer) Sale 2,758 7.87 21,705
2015-07-15 Adams Brian (VP and General Counsel) Sale 1,086 9.99 10,849
2015-07-06 Oliviero James F Iii (Chief Financial Officer) Sale 1,943 9.61 18,672
2015-05-12 Oliviero James F Iii (Chief Financial Officer) Option Ex 41,611 2.65 110,477
2015-05-06 Tarnok Michael P. (Director) Buy 10,000 9.73 97,300
2015-04-15 Adams Brian (VP and General Counsel) Sale 4,320 12.40 53,568
2015-04-06 Oliviero James F Iii (Chief Financial Officer) Sale 1,878 11.68 21,935
2015-04-06 Bentsur Ron (Chief Executive Officer) Sale 1,592 11.68 18,594
2015-03-06 Madison Greg (President and COO) Buy 6,380 12.53 79,941
2015-02-09 Madison Greg (President and COO) Sale 6,759 10.95 74,011
2015-01-05 Oliviero James F Iii (Chief Financial Officer) Sale 5,604 13.79 77,279
2015-01-05 Bentsur Ron (Chief Executive Officer) Sale 5,574 13.79 76,865
2014-12-30 Bentsur Ron (Chief Executive Officer) Sale 200,000 14.11 2,822,000
2014-12-29 Bentsur Ron (Chief Executive Officer) Sale 87,988 13.98 1,230,072
2014-12-26 Bentsur Ron (Chief Executive Officer) Sale 63,500 13.98 887,730
2014-12-24 Bentsur Ron (Chief Executive Officer) Sale 83,000 13.98 1,160,340
2014-12-23 Bentsur Ron (Chief Executive Officer) Sale 104,489 13.98 1,460,756
2014-12-10 Oliviero James F Iii (Chief Financial Officer) Sale 25,000 15.69 392,250
2014-12-10 Oliviero James F Iii (Chief Financial Officer) Option Ex 25,000 11.22 280,500
2014-10-06 Bentsur Ron (Chief Executive Officer) Sale 68,800 15.87 1,091,856
2014-10-03 Oliviero James F Iii (Chief Financial Officer) Sale 2,694 16.14 43,481
2014-10-03 Bentsur Ron (Chief Executive Officer) Sale 2,038 16.14 32,893
2014-09-12 Bentsur Ron (Chief Executive Officer) Sale 50,000 14.24 712,000
2014-09-08 Oliviero James F Iii (Chief Financial Officer) Sale 144,237 15.88 2,290,483
2014-07-07 Oliviero James F Iii (Chief Financial Officer) Sale 2,054 15.75 32,350
2014-07-07 Bentsur Ron (Chief Executive Officer) Sale 1,788 15.75 28,161

Insider trading activities including stock purchases, stock sales, and option exercises of KERX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Keryx Biopharmaceuticals Inc (symbol KERX, CIK number 1114220) see the Securities and Exchange Commission (SEC) website.



▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month




©2023, insider-monitor.com. All rights reserved.